Durgam Suresh K. — SEC Form 4 filings
SEC reporting owner CIK 1829958. 9 Form 4 filings on record with FilingPulse; latest filed 2025-04-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-05 to 2025-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 3 filings — 20,441 shares, $1,375,680 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 3,847 shares @ $67.49 ($259,634) in Intra-Cellular Therapies, Inc., filed 2024-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) | EVP, Chief Medical Officer | 9 | — | 10 legs · 20,441 sh · $1,375,680 | 32 |
Form 4 filings — Durgam Suresh K.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-02 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Disposition to issuer (D): 42,913 @ $132 · Disposition to issuer (D): 53,967 (derivative) · Disposition to issuer (D): 33,443 (derivative) · Disposition to issuer (D): 18,714 (derivative) · Disposition to issuer (D): 17,916 (derivative) · Disposition to issuer (D): 13,133 (derivative) · +6 more | EDGAR |
| 2025-03-10 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 13,133 · Tax withholding (F): 5,572 @ $131.19 · Option exercise (M): 7,345 · Tax withholding (F): 3,116 @ $131.24 · Option exercise (M): 13,133 (derivative) @ $0 · Option exercise (M): 7,345 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 8,742 · Tax withholding (F): 3,709 @ $128.20 · Option exercise (M): 8,742 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 11,017 @ $0 · Tax withholding (F): 4,730 @ $127 · Grant/award (A): 24,621 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Sale (S): 3,728 @ $66.34 · Sale (S): 2,722 @ $66.86 · Option exercise (M): 7,345 · Sale (S): 2,179 @ $65.06 · Sale (S): 872 @ $65.89 · Sale (S): 661 @ $66.96 · +1 more | EDGAR |
| 2024-03-08 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 13,132 · Option exercise (M): 13,132 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 26,227 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 7,907 · Sale (S): 1,400 @ $69.38 · Sale (S): 1,400 @ $70.16 · Sale (S): 1,312 @ $71.02 · Option exercise (M): 7,907 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 11,860 @ $0 · Sale (S): 2,320 @ $66.69 · Sale (S): 3,847 @ $67.49 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829958 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →